P-068 Oxidative stress and DNA fragmentation of spermatozoa in patients with cancer

Abstract Study question Does cancer increase sperm DNA fragmentation (sDF) level by increasing oxidative stress in human spermatozoa? Summary answer Cancer increases both sDF and oxidative stress, but further studies are necessary to understand whether higher levels of ROS are responsible for sperm...

Full description

Saved in:
Bibliographic Details
Published inHuman reproduction (Oxford) Vol. 37; no. Supplement_1
Main Authors Calamai, C, Ammar, O, Rosta, V, Krausz, C, Giovannelli, L, Muratori, M
Format Journal Article
LanguageEnglish
Published 29.06.2022
Online AccessGet full text

Cover

Loading…
Abstract Abstract Study question Does cancer increase sperm DNA fragmentation (sDF) level by increasing oxidative stress in human spermatozoa? Summary answer Cancer increases both sDF and oxidative stress, but further studies are necessary to understand whether higher levels of ROS are responsible for sperm DNA damage. What is known already In recent years, it has been emerging that not only oncological therapies but also cancer itself can induce abnormal spermatogenesis. In addition, several Authors reported that occurrence of malignancy provokes also increases of sperm DNA damage, although such finding was not confirmed by others and the possible mechanisms responsible for such damage are presently unknown Study design, size, duration This was a prospective observational study conducted from 2018 to today, conducted in 102 patients affected by cancer and in 66 control subjects. Participants/materials, setting, methods We recruited 102 patients affected by cancer and 66 male partners of infertile couples as control subjects, in the Andrology Clinic of University of Florence. Control subjects were normozoospermic with absence of leukocytospermia, semen viscosity, smoking habit and recent antibiotic therapies. In the recruited men, we evaluated standard semen parameters, sperm DNA Fragmentation with SCD (Sperm Chromatin Dispersion) Test and oxidative stress as percentage of viable spermatozoa with MitoSOX™ Red labeling on total viable spermatozoa. Main results and the role of chance We found poorer standard semen parameters (sperm motility, concentration and number) in cancer patients (both testicular and hematological ones) with respect to control group, whereas no differences were observed between the two types of cancer. Testicular, but not hematological patients, were younger than control subjects. No difference was seen in the other tested characteristics (sperm morphology, abstinence, semen volume and pH, BMI). Regarding sDF, we found higher median values [IQR] in cancer patients (total: 22.25[17.00-25.95], n = 68; hematological: 23.00[20.13-26.38], n = 28; testicular: 21.13[16.13-25.73], n = 40) vs control subjects (12.50[8.25-14.75], n = 53); p < 0.05, test U di Mann-Whitney. In addition, the amount of sperm oxidative stress was dramatically higher in patients with cancer (total:38.92[24.90-58.87], n = 79; hematological: 38.85[24.98-50.77], n = 34; testicular: 38.92[20.59-63.59], n = 45) vs control subjects (11.50[8.38-17.20], n = 62); p < 0.05, test U di Mann-Whitney. We also studied the occurrence of a correlation between levels of sDF and oxidative stress. We found a sharp correlation when both cancer patients and control subjects were analysed (Spearman coefficient = 0.62, p < 0.001, n = 103), but such correlation was completely lost when only cancer patients were considered (Spearman coefficient = 0.10, p > 0.05, n = 50). This finding suggests that mechanisms different from ROS attack to DNA could explain the increase of sDF levels in cancer patients. Limitations, reasons for caution The study did not investigate, because of scarce availability of semen samples from cancer patients, other possible mechanisms (i.e apoptosis, defects in sperm chromatin maturation, failure in DNA system repair) which could cause the observed increase of sperm DNA damage in such patients. Wider implications of the findings Cancer patients show high levels of both sDF and oxidative stress. This finding rises concern, as cancer patients cryopreserve semen for using it with Assisted Reproductive Tecnhologies and both parameters represent a threat for natural and assisted reproduction. In addition, emerging evidence suggest that oxidative stress may alter sperm epigenome. Trial registration number not applicable
AbstractList Abstract Study question Does cancer increase sperm DNA fragmentation (sDF) level by increasing oxidative stress in human spermatozoa? Summary answer Cancer increases both sDF and oxidative stress, but further studies are necessary to understand whether higher levels of ROS are responsible for sperm DNA damage. What is known already In recent years, it has been emerging that not only oncological therapies but also cancer itself can induce abnormal spermatogenesis. In addition, several Authors reported that occurrence of malignancy provokes also increases of sperm DNA damage, although such finding was not confirmed by others and the possible mechanisms responsible for such damage are presently unknown Study design, size, duration This was a prospective observational study conducted from 2018 to today, conducted in 102 patients affected by cancer and in 66 control subjects. Participants/materials, setting, methods We recruited 102 patients affected by cancer and 66 male partners of infertile couples as control subjects, in the Andrology Clinic of University of Florence. Control subjects were normozoospermic with absence of leukocytospermia, semen viscosity, smoking habit and recent antibiotic therapies. In the recruited men, we evaluated standard semen parameters, sperm DNA Fragmentation with SCD (Sperm Chromatin Dispersion) Test and oxidative stress as percentage of viable spermatozoa with MitoSOX™ Red labeling on total viable spermatozoa. Main results and the role of chance We found poorer standard semen parameters (sperm motility, concentration and number) in cancer patients (both testicular and hematological ones) with respect to control group, whereas no differences were observed between the two types of cancer. Testicular, but not hematological patients, were younger than control subjects. No difference was seen in the other tested characteristics (sperm morphology, abstinence, semen volume and pH, BMI). Regarding sDF, we found higher median values [IQR] in cancer patients (total: 22.25[17.00-25.95], n = 68; hematological: 23.00[20.13-26.38], n = 28; testicular: 21.13[16.13-25.73], n = 40) vs control subjects (12.50[8.25-14.75], n = 53); p < 0.05, test U di Mann-Whitney. In addition, the amount of sperm oxidative stress was dramatically higher in patients with cancer (total:38.92[24.90-58.87], n = 79; hematological: 38.85[24.98-50.77], n = 34; testicular: 38.92[20.59-63.59], n = 45) vs control subjects (11.50[8.38-17.20], n = 62); p < 0.05, test U di Mann-Whitney. We also studied the occurrence of a correlation between levels of sDF and oxidative stress. We found a sharp correlation when both cancer patients and control subjects were analysed (Spearman coefficient = 0.62, p < 0.001, n = 103), but such correlation was completely lost when only cancer patients were considered (Spearman coefficient = 0.10, p > 0.05, n = 50). This finding suggests that mechanisms different from ROS attack to DNA could explain the increase of sDF levels in cancer patients. Limitations, reasons for caution The study did not investigate, because of scarce availability of semen samples from cancer patients, other possible mechanisms (i.e apoptosis, defects in sperm chromatin maturation, failure in DNA system repair) which could cause the observed increase of sperm DNA damage in such patients. Wider implications of the findings Cancer patients show high levels of both sDF and oxidative stress. This finding rises concern, as cancer patients cryopreserve semen for using it with Assisted Reproductive Tecnhologies and both parameters represent a threat for natural and assisted reproduction. In addition, emerging evidence suggest that oxidative stress may alter sperm epigenome. Trial registration number not applicable
Author Muratori, M
Calamai, C
Giovannelli, L
Ammar, O
Rosta, V
Krausz, C
Author_xml – sequence: 1
  givenname: C
  surname: Calamai
  fullname: Calamai, C
– sequence: 2
  givenname: O
  surname: Ammar
  fullname: Ammar, O
– sequence: 3
  givenname: V
  surname: Rosta
  fullname: Rosta, V
– sequence: 4
  givenname: C
  surname: Krausz
  fullname: Krausz, C
– sequence: 5
  givenname: L
  surname: Giovannelli
  fullname: Giovannelli, L
– sequence: 6
  givenname: M
  surname: Muratori
  fullname: Muratori, M
BookMark eNotkEtOwzAURS1UJNLCBhh5A2mf87GdYVU-RaooAzqOnPiZBhE7ssN3hMROWQlG7ejeqyPdwZmSiXUWCblkMGdQ5Yv9a-9xWGhULQMxB16ckIQVHNIsL2FCEsi4TBnj7IxMQ3gGiFXyhOweUuDy9_tn-9FpNXZvSMPoMQSqrKZX90tqvHrq0Y4ROkudoWFA36vRfTlFO0uHCCIO9L0b97RVtkV_Tk6Negl4ccwZ2d1cP67W6WZ7e7dabtKWZWWRSi4aKFFyKatGoTG6yLTkVamZFNCUphKcaYnIC6FlA6LlKCtVCRVH1ph8RrLDb-tdCB5NPfiuV_6zZlD_i6kPYuqjmDqKyf8AeDtcng
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1093/humrep/deac107.064
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1460-2350
ExternalDocumentID 10_1093_humrep_deac107_064
GroupedDBID ---
-E4
.2P
.I3
.XZ
.ZR
0R~
1TH
29I
2WC
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
70D
AABZA
AACZT
AAIMJ
AAJKP
AAMDB
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AASNB
AAUAY
AAVAP
AAVLN
AAYXX
ABEUO
ABIXL
ABJNI
ABKDP
ABMNT
ABNHQ
ABNKS
ABPTD
ABQLI
ABQNK
ABWST
ABXVV
ABZBJ
ACCCW
ACGFS
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADEZT
ADGKP
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEJOX
AEKSI
AELWJ
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFGWE
AFIYH
AFOFC
AFXAL
AFXEN
AGINJ
AGKEF
AGQXC
AGSYK
AGUTN
AHMBA
AHXPO
AIJHB
AJEEA
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APWMN
ARIXL
ATGXG
AXUDD
AYOIW
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BQDIO
BSWAC
BTRTY
BVRKM
C45
CDBKE
CITATION
CS3
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBS
EE~
EMOBN
ENERS
F5P
F9B
FECEO
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IOX
J21
JXSIZ
KAQDR
KOP
KQ8
KSI
KSN
L7B
M-Z
M49
MHKGH
ML0
N9A
NGC
NLBLG
NOMLY
NOYVH
NU-
O9-
OAUYM
OAWHX
OBOKY
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
RIG
ROL
ROX
ROZ
RUSNO
RW1
RXO
TCURE
TEORI
TJX
TLC
TR2
W8F
WH7
WOQ
X7H
YAYTL
YKOAZ
YXANX
ZKX
~91
ID FETCH-LOGICAL-c1254-867b05e86889baeffd42d8695d1870b5f9761d8ee647d8b07c6e89a97a8b02bf3
ISSN 0268-1161
IngestDate Thu Sep 12 18:16:50 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue Supplement_1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1254-867b05e86889baeffd42d8695d1870b5f9761d8ee647d8b07c6e89a97a8b02bf3
OpenAccessLink https://academic.oup.com/humrep/article-pdf/37/Supplement_1/deac107.064/44306249/deac107.064.pdf
ParticipantIDs crossref_primary_10_1093_humrep_deac107_064
PublicationCentury 2000
PublicationDate 2022-06-29
PublicationDateYYYYMMDD 2022-06-29
PublicationDate_xml – month: 06
  year: 2022
  text: 2022-06-29
  day: 29
PublicationDecade 2020
PublicationTitle Human reproduction (Oxford)
PublicationYear 2022
SSID ssj0016186
Score 2.4328315
Snippet Abstract Study question Does cancer increase sperm DNA fragmentation (sDF) level by increasing oxidative stress in human spermatozoa? Summary answer Cancer...
SourceID crossref
SourceType Aggregation Database
Title P-068 Oxidative stress and DNA fragmentation of spermatozoa in patients with cancer
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9tAEF0VKlVcEIRWpXxoDxWXYPDHer0-RghEQQUOicTN2rXXbQ5xqpBIJCck_im_hNmdjW0qKhUulmPFozjztH4zO_OGkO8QcpQs8aWni1h7LM2FJ5QMTDFVrBKpgHHYAtkrfj5gF7fxbZNVst0lU3WUL17tK3mPV-Ea-NV0yb7Bs7VRuADn4F84gofh-F8-vjHDXFy5goiu74cFyni7BhBbZXzV65YT-WvkeowsOzTq4MBUx4ux7Dbaqq7RLTc4mLRJKyb6jfylVYdFwAhsNWxlEk4koAunWze7SiNXwX3d7Ow4wlpX115O5Oxu0dzmchAQvvrcc-ZxqQo5xKIByqofaVxKGfe9MEJZ2eVaiwIvDlN2bqlNgmbBq6s5Kl39no3gCeGkgJdEYCQnUff8pXj2Xy-1utQQN9mjDK1kzkYGNlbIx9CoAxom_eOy3noyAwQwMYeP5DqtwMYx2jhu_Y4Wm2nRkv4GWXfxBO0hODbJB111yFavAu-O5vSA2gpfu3XSIZ9-ukKKDjm4Qcny-SHtNx14d4f2jlrMfL5FBhZjTw-PNboooosCuiigi75AFx2XtIUuOqzoEl3UoIsiuj6Twdlp_-Tcc6M4vBwYMPMET5Qfa8GFSJXUZVmwsBA8jYsAFnwVl8Bqg0JozVlSCOUnOdcilWki4UOoyugLWa3Glf5KqK-0TYVEYcJZqgIVMQFBg58KM-xQxduku_xLsz-ouJL924nf3vTtHbLWwHeXrE4nM70HpHKq9i0IngGmLHi0
link.rule.ids 315,783,787,27937,27938
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=P-068%E2%80%83Oxidative+stress+and+DNA+fragmentation+of+spermatozoa+in+patients+with+cancer&rft.jtitle=Human+reproduction+%28Oxford%29&rft.au=Calamai%2C+C&rft.au=Ammar%2C+O&rft.au=Rosta%2C+V&rft.au=Krausz%2C+C&rft.date=2022-06-29&rft.issn=0268-1161&rft.eissn=1460-2350&rft.volume=37&rft.issue=Supplement_1&rft_id=info:doi/10.1093%2Fhumrep%2Fdeac107.064&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_humrep_deac107_064
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0268-1161&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0268-1161&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0268-1161&client=summon